Copyright
©The Author(s) 2020.
World J Clin Cases. Oct 26, 2020; 8(20): 4876-4882
Published online Oct 26, 2020. doi: 10.12998/wjcc.v8.i20.4876
Published online Oct 26, 2020. doi: 10.12998/wjcc.v8.i20.4876
Paliperidone form | Age/sex, country | Year | Underlying disease | Dose | Onset | Co-medication | Medication allergy | Presentations | Duration | Naranjo score[13] | Conclusion |
Oral | 19/F, Turkey[11] | 2015 | Schizophrenia | 6 mg/d | 2 h | None | None | Swelling of face, lips, & eyelids | 1 wk | 6 | Facial angioedema |
Injectable | 30/M, Greece[12] | 2017 | Schizophrenia | 150 mg monthly | 2nd month | None | Breathing difficulty from risperidone + lamotrigine | Sudden suffocation; seizure; & collapse in the house. | 2 d | 5 | Acute laryngeal edema with respiratory arrest |
Injectable | 79/F, Thailand | This report | Major neurocognitive disorder due to Alzheimer’s disease, type 2 diabetes, dyslipidemia, hypertension | Induction doses (150 mg; 100 mg) | 17th day | Donepezil, metformin, simvastatin, felodipine, atenolol | Aspirin | Intermittent swelling of face, lips, and eyelids | 23 d | 6 | Facial angioedema |
- Citation: Srifuengfung M, Sukakul T, Liangcheep C, Viravan N. Paliperidone palmitate-induced facial angioedema: A case report. World J Clin Cases 2020; 8(20): 4876-4882
- URL: https://www.wjgnet.com/2307-8960/full/v8/i20/4876.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i20.4876